Risk factors
Inovio Pharmaceuticals (INO) risk factors
Item 1A of every Inovio Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors60 risks9 new4 dropped14 reworded
Going concern doubts raised with $58.5M cash funding operations only into fourth quarter of 2026.
Filed Mar 12, 2026 - FY2024 10-K risk factors55 risks
Operating losses reached $1.7 billion as of December 31, 2024, with minimal revenues from licenses and grants.
Filed Mar 18, 2025